We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

41 hedge funds and large institutions have $35.6M invested in Genocea Biosciences, Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more capital invested

Capital invested by funds: $13.7M → $35.6M (+$21.9M)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

5% less funds holding

Funds holding: 43 → 41 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
41
Holders Change
-2
Holders Change %
-4.65%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
9
Reduced
9
Closed
7
Calls
$885K
Puts
–
Net Calls
+$885K
Net Calls Change
+$455K

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$6.15M
2
BI
BVF Inc
California
+$1.68M
3
DCM
DAFNA Capital Management
California
+$1.23M
4
HighTower Advisors
HighTower Advisors
Illinois
+$142K
5
Renaissance Technologies
Renaissance Technologies
New York
+$132K

Top Sellers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
-$943K
2
DS
DRW Securities
Illinois
-$230K
3
VC
Vivo Capital
California
-$228K
4
Millennium Management
Millennium Management
New York
-$20K
5
VF
Virtu Financial
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$10K +$10.3K +2,075 New
QOP
27
Quinn Opportunity Partners
Virginia
$9K – – –
Citigroup
28
Citigroup
New York
$8K – – –
JMFC
29
J.M. Forbes & Co
Massachusetts
$8K – – –
FANJ
30
Financial Architects (New Jersey)
New Jersey
$7K – – –
Squarepoint
31
Squarepoint
New York
$6K -$12.6K -2,551 -67%
IA
32
IFP Advisors
Florida
$6K -$94 -19 -1%
TSS
33
Two Sigma Securities
New York
$6K -$59 -12 -0.9%
AWA
34
Artemis Wealth Advisors
New York
$5.37K – – –
Wells Fargo
35
Wells Fargo
California
$5K -$618 -125 -10%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$4K +$4.02K +813 +1,213%
Federated Hermes
37
Federated Hermes
Pennsylvania
$2K – – –
CFA
38
Carroll Financial Associates
North Carolina
$1K – – –
DS
39
DRW Securities
Illinois
– -$230K -100,114 Closed
Millennium Management
40
Millennium Management
New York
– -$20K -8,759 Closed
VF
41
Virtu Financial
New York
– -$16K -7,152 Closed
Citadel Advisors
42
Citadel Advisors
Florida
– -$11K -4,989 Closed
Jane Street
43
Jane Street
New York
– -$4K -1,808 Closed
Invesco
44
Invesco
Georgia
– -$4K -1,627 Closed
FNC
45
First National Corp
Massachusetts
– +$277 +56 New
1
2

GNCA Hedge Fund Activity: Q1 2019 in Review

41 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2019, worth a combined $35.6M — up 159% from $13.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GNCA and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was NEA Management Company, adding an estimated $6.15M. The largest seller was Ghost Tree Capital, cutting an estimated $943K.

  • 41 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2019, down from 43 in Q4 2018.
  • Funds reported $35.6M of Genocea Biosciences, Inc. stock for Q1 2019, up 159% quarter-over-quarter.
  • 5 funds opened new Genocea Biosciences, Inc. positions in Q1 2019 and 7 closed out, a net change of -2 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q1 2019 was NEA Management Company, an estimated $6.15M added.
  • The largest Genocea Biosciences, Inc. seller in Q1 2019 was Ghost Tree Capital, an estimated $943K sold.

Based on aggregated 13F filings for Q1 2019.